Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics

While protein therapeutics are indispensable in the treatment of a variety of diseases, including cancer, rheumatoid arthritis, and diabetes, key limitations including short half-lives, high immunogenicity, protein instability, and centralized production complicate long-term use and on-demand produc...

Full description

Bibliographic Details
Main Author: Wilding, Kristen Michelle
Format: Others
Published: BYU ScholarsArchive 2018
Subjects:
Online Access:https://scholarsarchive.byu.edu/etd/7713
https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8713&context=etd
id ndltd-BGMYU2-oai-scholarsarchive.byu.edu-etd-8713
record_format oai_dc
spelling ndltd-BGMYU2-oai-scholarsarchive.byu.edu-etd-87132020-07-15T07:09:31Z Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics Wilding, Kristen Michelle While protein therapeutics are indispensable in the treatment of a variety of diseases, including cancer, rheumatoid arthritis, and diabetes, key limitations including short half-lives, high immunogenicity, protein instability, and centralized production complicate long-term use and on-demand production. Site-specific polymer conjugation provides a method for mitigating these challenges while minimizing negative impacts on protein activity. However, the location-dependent effects of polymer conjugation are not well understood. Cell-free protein synthesis provides direct access to the synthesis environment and rapid synthesis times, enabling rapid evaluation of multiple conjugation sites on a target protein. Here, work is presented towards developing cell-free protein synthesis as a platform for both design and on-demand production of next generation polymer-protein therapeutics, including (1) eliminating endotoxin contamination in cell-free reagents for simplified therapeutic preparation, (2) improving shelf-stability of cell-free reagents via lyophilization for on-demand production, (3) coupling coarse-grain simulation with high-throughput cell-free protein synthesis to enable rapid identification of optimal polymer conjugation sites, and (4) optimizing cell-free protein synthesis for production of therapeutic proteins 2018-12-01T08:00:00Z text application/pdf https://scholarsarchive.byu.edu/etd/7713 https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8713&context=etd http://lib.byu.edu/about/copyright/ Theses and Dissertations BYU ScholarsArchive synthetic biology cell-free protein synthesis endotoxin removal lyophilization lyoprotectant unnatural amino acid high-throughput screening Engineering
collection NDLTD
format Others
sources NDLTD
topic synthetic biology
cell-free protein synthesis
endotoxin removal
lyophilization
lyoprotectant
unnatural amino acid
high-throughput screening
Engineering
spellingShingle synthetic biology
cell-free protein synthesis
endotoxin removal
lyophilization
lyoprotectant
unnatural amino acid
high-throughput screening
Engineering
Wilding, Kristen Michelle
Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics
description While protein therapeutics are indispensable in the treatment of a variety of diseases, including cancer, rheumatoid arthritis, and diabetes, key limitations including short half-lives, high immunogenicity, protein instability, and centralized production complicate long-term use and on-demand production. Site-specific polymer conjugation provides a method for mitigating these challenges while minimizing negative impacts on protein activity. However, the location-dependent effects of polymer conjugation are not well understood. Cell-free protein synthesis provides direct access to the synthesis environment and rapid synthesis times, enabling rapid evaluation of multiple conjugation sites on a target protein. Here, work is presented towards developing cell-free protein synthesis as a platform for both design and on-demand production of next generation polymer-protein therapeutics, including (1) eliminating endotoxin contamination in cell-free reagents for simplified therapeutic preparation, (2) improving shelf-stability of cell-free reagents via lyophilization for on-demand production, (3) coupling coarse-grain simulation with high-throughput cell-free protein synthesis to enable rapid identification of optimal polymer conjugation sites, and (4) optimizing cell-free protein synthesis for production of therapeutic proteins
author Wilding, Kristen Michelle
author_facet Wilding, Kristen Michelle
author_sort Wilding, Kristen Michelle
title Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics
title_short Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics
title_full Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics
title_fullStr Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics
title_full_unstemmed Engineering Cell-Free Biosystems for On-Site Production and Rapid Design of Next-Generation Therapeutics
title_sort engineering cell-free biosystems for on-site production and rapid design of next-generation therapeutics
publisher BYU ScholarsArchive
publishDate 2018
url https://scholarsarchive.byu.edu/etd/7713
https://scholarsarchive.byu.edu/cgi/viewcontent.cgi?article=8713&context=etd
work_keys_str_mv AT wildingkristenmichelle engineeringcellfreebiosystemsforonsiteproductionandrapiddesignofnextgenerationtherapeutics
_version_ 1719325232694558720